Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06965712 · ClinicalTrials.gov registry record · NA

Use of Point-of-Care Ultrasound (POCUS) to Reduce Hospital Length of Stay in Patients With Heart Failure ( POCUSHF )

A NA study of Heart Failure and Decompensated Heart Failure, sponsored by Florida International University.

Recruiting
Registry status
NA
Development phase
66
Enrollment target
1
Study location

NCT06965712: Recruiting NA study of Heart Failure and Decompensated Heart Failure, sponsored by Florida International University.

NCT06965712 is a NA study of Heart Failure and Decompensated Heart Failure that is actively recruiting participants, run by Florida International University. The registered enrollment target is 66 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06965712, a NA study of Heart Failure and Decompensated Heart Failure, is actively recruiting participants, sponsored by Florida International University.

RECRUITING
Registry status
NA
Development phase
66 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate whether using bedside ultrasound (also called Point-of-Care Ultrasound or POCUS) can help improve the care of hospitalized patients with decompensated heart failure. Patients will be randomly assigned to two groups: one group will receive ultrasound-guided assessments, and the other group will receive standard clinical evaluations. Researchers will compare the hospital length of stay between the two groups. Ultrasound is a non-invasive, safe, and painless imaging tool. The goal of the study is to find out if ultrasound guidance can lead to shorter hospitalizations and better care for patients with heart failure.

Primary Outcome

Hospital Length of Stay (LOS) will be measured as the number of days from hospital admission to discharge decision. LOS will be compared between the POCUS-guided group and the standard care group.

Interventions

  • DEVICE Point-of-Care Ultrasound (POCUS)

Study Locations (1)

Florida

  • Jackson Memorial Hospital - Miami

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2025-11-24
Est. Completion 2026-06-30
Phase NA
Florida International University

89 total trials

What NCT06965712 shows while recruiting

NCT06965712 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower).

The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Point-of-Care Ultrasound (POCUS) is the first listed.

NCT06965712 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06965712 about?

NCT06965712 is a clinical study titled "Use of Point-of-Care Ultrasound (POCUS) to Reduce Hospital Length of Stay in Patients With Heart Failure ( POCUSHF )". This study will evaluate whether using bedside ultrasound (also called Point-of-Care Ultrasound or POCUS) can help improve the care of hospitalized patients with decompensated heart failure. Patients will be randomly assigned to two groups: one group will receive ultrasound-guided assessments, and t...

What is the current status of trial NCT06965712?

This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2025-11-24. Estimated completion is 2026-06-30.

What conditions does trial NCT06965712 study?

This clinical trial studies the following conditions: Heart Failure, Decompensated Heart Failure, Hospital Length of Stay.

What interventions are being tested in trial NCT06965712?

The interventions under investigation include: Point-of-Care Ultrasound (POCUS) (DEVICE).

Who is sponsoring clinical trial NCT06965712?

This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06965712 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06965712's enrollment target sits among peer trials

66 251st of 397 higher than 147 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02584244 · 66 participants · Phase 1

    Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

  • NCT03067051 · 66 participants · Phase 1

    Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

  • NCT03754725 · 66 participants · Phase 1

    Ferritin and Iron Burden in SAH sIRB

  • NCT03875378 · 66 participants · Phase 2

    Transdermal Estrogen in Women With Anorexia Nervosa

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06965712, the US trial registry maintained by the National Library of Medicine. NCT06965712 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.